MagicBox Recognised as Leader in G2 Summer 2025 Grid® Report for Digital Learning Platforms
This prestigious recognition is based on verified reviews and ratings provided by real users of MagicBox, who evaluated the platform across a range of performance metrics including user satisfaction, platform functionality, support, and ease of use.
"Being named a Grid Leader by G2 is a direct reflection of the value our users see in MagicBox," said Satadeep Mitra, Chief Strategy Officer at MagicBox. "Our mission is to empower educators and publishers with scalable, accessible, and inclusive digital learning solutions —and this recognition validates our continued efforts toward that goal."
To qualify for inclusion in the G2 Grid Report, products must meet specific criteria based on verified user feedback. MagicBox earned the Grid ® Leader badge thanks to consistently positive reviews and high satisfaction scores from educators, publishers, and administrators who rely on the platform for secure and effective digital learning delivery.
"Every quarter, G2 ranks the best products across thousands of reports by category, company size, geography, and report type," said Sydney Sloan, CMO of G2. "These reports serve as tailored guides for software buyers researching solutions that meet their specific business needs. Congratulations to MagicBox for appearing in our G2 Reports this season, thanks to the positive experiences shared by their customers."
Explore what real users have to say about MagicBox—or leave a review—by visiting the MagicBox review page on G2.
About Magic EdTech
Based in New York, Magic EdTech is an educational technology and content services company that delivers digital learning products. Magic brings a deep understanding of serving the education markets – with a mission to deliver digital learning for everyone, which it has been pursuing for over two decades with a team of 1300+ experts. Its flagship platform, MagicBox, is focused on creating and conceptualizing digital learning solutions for K-12 and higher education. For any further information, please get in touch with us at [email protected].
www.g2.com and follow us on LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
20 hours ago
- Cision Canada
Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats
TORONTO, July 2, 2025 /CNW/ - Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept), a biosimilar to Eylea®, indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema secondary to central or branch retinal vein occlusion, treatment of diabetic macular edema, and treatment of myopic choroidal neovascularization. This approval marks a key milestone for Apotex, introducing its first ophthalmic biosimilar and its fourth biosimilar since 2016, and reflecting the Company's commitment to expand its biologics portfolio and execution of its Journey of Health strategy. "With Aflivu, we're expanding affordable treatment options for Canadians affected by retinal diseases," said Raymond Shelley, President, Apotex Canada. "Apotex continues to deliver innovative, patient-focused solutions across our growing portfolio of brands, biosimilars, generics and consumer health products." "The approval of Aflivu represents a positive advancement in ophthalmic care," said Dr. Bernard R. Hurley, BSc, MD, FRCSC, Assistant Professor at the University of Ottawa Eye Institute. "Biosimilars, supported by clinicians, regulators, and manufacturers, have the potential to transform the treatment landscape for retinal diseases, preserving vision and providing quality, cost-effective care for countless Canadians." "In clinical practice, having access to a broader range of therapeutic options can empower physicians to tailor care to individual patients' needs," said Dr. Ghassan Cordahi, MD, FACS, Assistant Clinical Professor, Faculty of Medicine, Department of Ophthalmology, Université de Montréal. "Aflibercept has been a cornerstone in managing retinal diseases, and the introduction of Aflivu offers a more affordable alternative without compromising quality." Aflivu joins Apotex's successful biosimilar portfolio, which includes Grastofil® (filgrastim), Lapelga® (pegfilgrastim), and Bambevi® (bevacizumab). About Apotex Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions.
Globe and Mail
20 hours ago
- Globe and Mail
GE Vernova Wins Puerto Rico Turbine Deal: What Lies Ahead for the Stock?
GE Vernova Inc. GEV recently secured an order from Puerto Rico's RG Engineering to deliver six of its LM2500XPRESS aeroderivative gas turbine packages. Notably, GEV's LM2500XPRESS turbines can be installed quickly, with the ability to achieve up to 39.5% efficiency in simple cycle configuration and up to 54.4% efficiency in combined cycle configuration. As Puerto Rico continues to face energy challenges following severe damage to its grid from Hurricanes Maria (2017) and Fiona (2022), these turbines, with a total electricity generating capacity of approximately 244 megawatts (MW), will help strengthen this territory's grid stability, meet peak summer demand and provide emergency power. This order underscores GE Vernova's expanding footprint in the global gas power industry, thereby enhancing its investment appeal for those looking to add a resilient energy stock to their portfolio. However, before making any hasty decision, let's delve deep into the company's performance of late (in terms of share price movement), future growth prospects as well as risks (if any) to investing in the same. This way, an investor can make an informed decision. GEV Stock Outperforms Industry, Sector & S&P 500 Shares of GE Vernova have surged an impressive 53.8% in the year-to-date period, outperforming the Zacks Alternative-Energy industry 's growth of 23.5% and the broader Zacks Oils-Energy sector 's rise of 0.3%. It has also outpaced the S&P 500's growth of 4.9% over the same period. A similar stellar performance has been delivered by other industry players, such as Talen Energy Corp. TLN and Constellation Energy Corp. CEG, whose shares have surged 39% and 37.6%, respectively, year to date. What Pushed GEV Stock Up? As industries worldwide shift to sustainable energy, GE Vernova supports this transition with advanced technologies that reduce emissions. Its recent clean energy initiatives and growing presence in the low-carbon power sector have likely strengthened investor confidence, as reflected in the year-to-date share price gain. Impressively, in June 2025, GEV secured an order from Rio Tinto, one of Canada's largest private producers of hydroelectricity, for the upgrade of eight turbine-alternator units at the Isle Maligne hydropower plant of Canada. In the same month, GE Vernova Hitachi Nuclear Energy, an alliance between GEV and Hitachi, signed an agreement with the Nordic energy company, Fortum, to enhance potential deployment of the BWRX-300 small modular reactor (SMR) in Finland and Sweden. The company also signed an agreement to supply, service, and commission 12 of its 6.1 MW-158m onshore wind workhorse turbines for Çal??k Renewables's Zatriq I & II Wind Farms, last month. In May, GEV revealed that it will deliver two gas-insulated substations (GIS) in Norway, utilizing its g³ technology to reduce greenhouse gas emissions. In the same month, GEV's LM Wind Power signed a deal with Vestas Wind Systems for a wind turbine blade factory in Poland. Earlier in April, the company signed a significant partnership with Duke Energy for natural gas turbines and other associated equipment to meet America's growing energy demand. GEV entered this year with a $20 million investment plan, supported by Singapore's EDB, to develop next-generation repair technologies for its HA gas turbines at its Global Repair Service Center. What Lies Ahead for GEV Stock? With global electricity consumption expected to rise 3.9% in 2025 and around 4% annually through 2027 (IEA), demand for clean, efficient, and scalable energy solutions is set to soar. GE Vernova's consistent stream of project wins, strategic partnerships, and technology collaborations across hydropower, nuclear, wind, and gas positions it to benefit from this trend. The company's recent initiatives, spanning North America, Europe, and Asia (as mentioned above), underscore its readiness to meet rising energy needs through innovative solutions. This strong alignment between GE Vernova's expanding global operations and projected electricity demand growth supports its long-term revenue and earnings growth potential. In line with this, the Zacks Consensus Estimate for GEV's long-term (three-to-five years) earnings growth rate is pegged at a solid 18%. In fact, the growing demand for electricity from renewable sources worldwide has also been bolstering the long-term growth prospects of other clean energy stocks, such as TLN and CEG. Notably, the long-term earnings growth rate for TLN is 5.2%, while that for CEG is 13.5%. However, a prospective investor should be aware of the challenges that GE Vernova is currently facing, particularly in the offshore wind industry. Notably, the offshore wind industry has been struggling with rising material costs and persistent supply-chain issues for some time now, resulting in multiple project cancellations. As a wind turbine manufacturer, GEV has thus been witnessing increased product and project costs, along with delays in execution timelines. This, in turn, is impacting its offshore wind business' performance, as evident from the 53.7% year-over-year decline in its first-quarter offshore wind revenues (owing to a slower pace of production). Looking ahead, the company's offshore wind business is expected to continue delivering poor performance in the near future, further corroborated by the order decline in this business segment, which may lead to notable financial losses. Now, let's take a quick look at GEV's near-term estimates to see what growth story they depict. Estimates for GEV The Zacks Consensus Estimate for 2025 and 2026 sales implies an improvement of 6.5% and 10%, respectively, year over year. A similar improvement can be witnessed in the company's 2025 and 2026 earnings estimates. Moreover, near-term earnings estimate has shown solid improvement over the past 60 days, except for 2025. The upward revision in earnings estimates indicates analysts' increasing confidence in the stock's earnings-generating capabilities, while the downward revision reflects declining confidence in the same. Image Source: Zacks Investment Research GEV Stock Trading at a Premium In terms of valuation, GEV's forward 12-month price-to-earnings (P/E) is 53.71X, a premium to its peer group's average of 15.22X. This suggests that investors will be paying a higher price than the company's expected earnings growth compared to its peers. Its industry peers are also trading at a premium. While TLN is trading at a forward 12-month earnings of 27.67X, CEG is trading at 29.34X. Final Thoughts To conclude, investors considering GE Vernova may want to wait for a more attractive entry point, considering its currently stretched valuation. However, existing shareholders of this Zacks Rank #3 (Hold) company may continue to retain it, as its robust year-to-date price performance, steady order wins across key clean energy segments, and solid earnings growth potential, supported by upbeat sales estimates and long-term demand projections, signal encouraging prospects. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Constellation Energy Corporation (CEG): Free Stock Analysis Report Talen Energy Corporation (TLN): Free Stock Analysis Report GE Vernova Inc. (GEV): Free Stock Analysis Report
Cision Canada
21 hours ago
- Cision Canada
KPM Analytics Expands Vision Inspection Manufacturing Facilities to Support Baking and Snack Food Brands
The modern, state-of-the-art facility in Trento, Italy, will become the new home for advanced Artificial Intelligence (AI) powered vision quality and food safety inspection for KPM Analytics' EyePro System product brand. WESTBOROUGH, Mass., July 2, 2025 /CNW/ -- KPM Analytics has announced a significant expansion of its vision inspection system manufacturing facility to meet increasing demand from baking and snack food producers seeking to elevate quality control and food safety on the line. The 22,000 sq ft. operation is located at Viale dell'Industria 2, Pergine Valsugana (TN), 38057, Italy. The new facility more than doubles the production capacity for the company's industry-leading line of vision inspection systems, including the well-known Q-Bake™ In-Line Vision Inspection System, the EyePro Laner for packaging lane balancing, and the TheiaVu ® E-Series At-Line Vision Measurement System. On high-speed baking and snack food production lines, KPM Analytics' vision inspection systems detect and monitor product quality and safety attributes such as color, shape, size, topping, and foreign material contamination. In addition to producing inspection systems, the site will host factory acceptance testing, customer training, and hands-on demonstrations to help baking and snack food operators get the most from their equipment from day one. Additionally, the new location has dedicated facilities for developing advanced hardware and software applications for improved food safety, including hyperspectral imaging and artificial intelligence model development for foreign material detection. According to KPM Analytics' General Manager for Vision Inspection Technologies, Andrea Bertuolo, "the facility expansion is a direct response to the growing needs of our customers who are under increasing pressure to meet rigorous quality standards. With the extra capacity, we are better prepared to improve our production throughput to meet their evolving demands." KPM Analytics acquired EyePro System, S.r.l., in 2021, representing a significant moment in KPM Analytics' mission to assist food processors in their efforts to control product quality and amplify food safety throughout their organizations. Its vision inspection products have been a top choice among baking and snack makers to achieve 100% in-line inspection and automatic defect removal in their processing lines. In recent years, the division's emphasis on progressive applications that merge quality inspection with AI machine learning for advanced foreign material detection has elevated the brand into a higher echelon to help food brands excel in their quality assurance and food safety efforts. "Baking and snack brands are facing tighter quality specs and higher volumes. The ability to catch defects, process deviations, or foreign materials instantly – not downstream – is essential," says KPM Analytics' Chief Executive Officer Brian Mitchell. "The investment in our new vision inspection facility ensures we meet customer expectations more effectively while continuing to innovate alongside them." The new Pergine Valsugana location joins KPM Analytics' 11 other manufacturing, sales, and support offices worldwide and is the latest business expansion investment following similar projects in Orem, Utah USA, Villeneuve, France, Ottawa Ontario Canada and Westborough, MA USA. About KPM Analytics KPM Analytics is a global leader in scientific instrumentation and vision process machinery, focused primarily on analyzing critical parameters within the food, feed, agriculture, and environmental sectors. We provide a comprehensive range of products and services to solve our customers' problems uniquely. Our brands include AMS, Bruins Instruments, CHOPIN Technologies, EyePro System, Process Sensors, Sensortech, Sightline, Smart Vision Works, and Unity Scientific. Each has a long history of delivering advanced and reliable analysis solutions to ensure product quality and optimize process efficiency, with customer service at the center of everything we do. Visit to learn more. Media contacts: Andy Dambeck Marketing Manager [email protected] 774-399-0477 SOURCE KPM Analytics
